Oncternal Therapeutics In... (ONCT)
0.53
-0.16 (-23.63%)
At close: Dec 02, 2024, 9:00 PM
13F Institute Ownership
Total Institutes of 37 in Oncternal Therapeutics reduced their positions with a decrease of 14 investors compared to the previous quarter. A reduction of 943.17K shares, as total invested capital grew by $1.69M with ownership percentage dropping from 15.89% to 14.22%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| JPMORGAN Chase & Co | < 0.01% | 0 | - | 0 | < 0.01% |
| Bank Of America Corp /de/ | < 0.01% | 0 | - | 0 | < 0.01% |
| Wells Fargo & Company/mn | < 0.01% | 0 | - | 0 | < 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.